Schinder A F, Montal M
Department of Biology, University of California San Diego, La Jolla 92093-0319.
FEBS Lett. 1993 Oct 11;332(1-2):44-8. doi: 10.1016/0014-5793(93)80480-i.
Repetitive stimulation of glutamate (glu) receptors elicits increasingly smaller ionic currents in hippocampal neurons. To investigate mechanisms underlying this phenomenon, voltage clamp whole-cell currents evoked by glu (100 microM) were recorded from hippocampal neurons in culture. These currents were primarily carried by N-methyl-D-aspartate-receptor (NMDA-R) channels, as shown by the voltage-dependent sensitivity to extracellular Mg2+ blockade, and inhibition by the specific antagonist MK-801. In the presence of 2.2 mM extracellular Ca2+ ([Ca2+]e), repetitive glu applications (15 episodes of 4 s/min) elicited progressively smaller currents that stabilized at 45% of their initial peak value. Replacement of [Ca2+]e by Ba2+ produced similar effects. This phenomenon, defined as interepisode inactivation, was exacerbated by elevating [Ca2+]e to 11 mM, attenuated by reducing [Ca2+]e to 0.22 mM, and further diminished by shortening the length of the glu pulse to 2 s. Current decay exhibited during individual stimuli, or intraepisode inactivation, was dependent on [Ca2+]e yet remained stable during repetitive stimulation. We conclude that interepisode and intraepisode inactivations of NMDA-R currents are the expression of two distinct processes triggered by Ca2+. These modalities of inactivation may arise from Ca2+ binding either to the receptor or to closely associated regulatory proteins.
对谷氨酸(glu)受体的重复刺激会使海马神经元中的离子电流越来越小。为了研究这种现象背后的机制,我们从培养的海马神经元中记录了由glu(100微摩尔)诱发的电压钳全细胞电流。这些电流主要由N-甲基-D-天冬氨酸受体(NMDA-R)通道传导,这可通过对细胞外Mg2+阻断的电压依赖性敏感性以及特异性拮抗剂MK-801的抑制作用来证明。在存在2.2毫摩尔细胞外Ca2+([Ca2+]e)的情况下,重复施加glu(以每分钟4次的频率施加15次,每次4秒)会引起电流逐渐减小,并稳定在其初始峰值的45%。用Ba2+替代[Ca2+]e会产生类似的效果。这种现象被定义为发作间期失活,通过将[Ca2+]e提高到11毫摩尔会加剧,通过将[Ca2+]e降低到0.22毫摩尔会减弱,并且通过将glu脉冲长度缩短到2秒会进一步减小。在单个刺激期间表现出的电流衰减,即发作期内失活,取决于[Ca2+]e,但在重复刺激期间保持稳定。我们得出结论,NMDA-R电流的发作间期和发作期内失活是由Ca2+触发的两个不同过程的表现。这些失活方式可能源于Ca2+与受体或紧密相关的调节蛋白结合。